Fibrosis [clinicaltrials_resource:af970820d839486f4d844e35053538a3]
Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis [clinicaltrials:NCT00001437]Combination Drug Therapy for Patients With Hepatitis C [clinicaltrials:NCT00001729]clinicaltrials:NCT00001959clinicaltrials:NCT00039871Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis [clinicaltrials:NCT00148837]Pergolide Treatment and Valvular Heart Disease [clinicaltrials:NCT00234364]Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C [clinicaltrials:NCT00252642]clinicaltrials:NCT00347009clinicaltrials:NCT00455767clinicaltrials:NCT00583700Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease [clinicaltrials:NCT00629603]clinicaltrials:NCT00655018Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes [clinicaltrials:NCT00707421]clinicaltrials:NCT00744939Safety of Gadovist in Renally Impaired Patients [clinicaltrials:NCT00828737]clinicaltrials:NCT01040104Use of Bevacizumab in Trabeculectomy Surgery [clinicaltrials:NCT01166594]The Fibrosis-Lymphedema Continuum in Head and Neck Cancer [clinicaltrials:NCT01187173]A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) [clinicaltrials:NCT01203943]Examination of Left Atrial Fibrosis Using MRI [clinicaltrials:NCT01233674]Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy [clinicaltrials:NCT01246388]clinicaltrials:NCT01268202Study on Immunopathogenesis in HIV and Hepatitis C Coinfection [clinicaltrials:NCT01296529]clinicaltrials:NCT01483248HIV Accelerated Liver Disease in Uganda [clinicaltrials:NCT01524562]Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure [clinicaltrials:NCT01587222]Fibrosis a New Pathological Actor in Adipose Tissue [clinicaltrials:NCT01655017]clinicaltrials:NCT01813045clinicaltrials:NCT01822405clinicaltrials:NCT01837160Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using Fibroscan [clinicaltrials:NCT01898325]Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars [clinicaltrials:NCT01978301]Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial [clinicaltrials:NCT02049307]clinicaltrials:NCT02057965Non-invasive Methods Questionnaire [clinicaltrials:NCT02132351]Pirfenidone, an Antifibrotic and Antiinflammatory Drug [clinicaltrials:NCT02161952]Knee Stiffness in Fibrosis Diathesis [clinicaltrials:NCT02294890]clinicaltrials:NCT02327689clinicaltrials:NCT02384733Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease [clinicaltrials:NCT02408744]
condition [clinicaltrials_vocabulary:condition]
Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders [clinicaltrials:NCT00001223]Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis [clinicaltrials:NCT00001437]clinicaltrials:NCT00001596Lung Disease Associated With Rheumatoid Arthritis [clinicaltrials:NCT00001876]Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis [clinicaltrials:NCT00001884]Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis [clinicaltrials:NCT00001885]Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis [clinicaltrials:NCT00004287]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease [clinicaltrials:NCT00004315]Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis [clinicaltrials:NCT00004428]Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [clinicaltrials:NCT00004440]Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [clinicaltrials:NCT00004441]Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer [clinicaltrials:NCT00004471]Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis [clinicaltrials:NCT00004489]Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [clinicaltrials:NCT00004533]Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis [clinicaltrials:NCT00004705]Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis [clinicaltrials:NCT00004747]Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis [clinicaltrials:NCT00004779]Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis [clinicaltrials:NCT00004806]Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [clinicaltrials:NCT00004829]A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis [clinicaltrials:NCT00005110]Growth Hormone Use in Cystic Fibrosis - a Multicenter Study [clinicaltrials:NCT00005112]Idiopathic Pulmonary Fibrosis: a Case-control Study [clinicaltrials:NCT00005295]Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases [clinicaltrials:NCT00005317]Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis [clinicaltrials:NCT00006063]Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis [clinicaltrials:NCT00006273]A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [clinicaltrials:NCT00006280]Bone Health of People With Cystic Fibrosis [clinicaltrials:NCT00008762]Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis [clinicaltrials:NCT00014768]Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis [clinicaltrials:NCT00014781]Benefits and Risks of Newborn Screening for Cystic Fibrosis [clinicaltrials:NCT00014950]Tissue Collection From People With Cystic Fibrosis [clinicaltrials:NCT00015756]Phase II Study of Growth Hormone in Children With Cystic Fibrosis [clinicaltrials:NCT00016445]Linkage Study in Familial Pulmonary Fibrosis [clinicaltrials:NCT00016627]Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [clinicaltrials:NCT00016744]Low-Dose Radiation to Prevent Complications of Back Surgery [clinicaltrials:NCT00018876]Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer [clinicaltrials:NCT00020631]Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging [clinicaltrials:NCT00023465]A Study in Adult and Pediatric Patients With Cystic Fibrosis [clinicaltrials:NCT00034515]Gene Modifiers of Cystic Fibrosis Lung Disease [clinicaltrials:NCT00037765]
condition browse [clinicaltrials_vocabulary:condition-browse]
Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders [clinicaltrials:NCT00001223]Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis [clinicaltrials:NCT00001437]clinicaltrials:NCT00001596Lung Disease Associated With Rheumatoid Arthritis [clinicaltrials:NCT00001876]Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis [clinicaltrials:NCT00001884]Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis [clinicaltrials:NCT00001885]Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis [clinicaltrials:NCT00004287]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease [clinicaltrials:NCT00004315]Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis [clinicaltrials:NCT00004428]Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [clinicaltrials:NCT00004440]Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [clinicaltrials:NCT00004441]Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer [clinicaltrials:NCT00004471]Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis [clinicaltrials:NCT00004489]Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [clinicaltrials:NCT00004533]Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis [clinicaltrials:NCT00004705]Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis [clinicaltrials:NCT00004747]Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis [clinicaltrials:NCT00004779]Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis [clinicaltrials:NCT00004806]Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [clinicaltrials:NCT00004829]A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis [clinicaltrials:NCT00005110]Growth Hormone Use in Cystic Fibrosis - a Multicenter Study [clinicaltrials:NCT00005112]Idiopathic Pulmonary Fibrosis: a Case-control Study [clinicaltrials:NCT00005295]Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases [clinicaltrials:NCT00005317]Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis [clinicaltrials:NCT00006063]Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis [clinicaltrials:NCT00006273]A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [clinicaltrials:NCT00006280]Bone Health of People With Cystic Fibrosis [clinicaltrials:NCT00008762]Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis [clinicaltrials:NCT00014768]Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis [clinicaltrials:NCT00014781]Benefits and Risks of Newborn Screening for Cystic Fibrosis [clinicaltrials:NCT00014950]Tissue Collection From People With Cystic Fibrosis [clinicaltrials:NCT00015756]Phase II Study of Growth Hormone in Children With Cystic Fibrosis [clinicaltrials:NCT00016445]Linkage Study in Familial Pulmonary Fibrosis [clinicaltrials:NCT00016627]Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [clinicaltrials:NCT00016744]Low-Dose Radiation to Prevent Complications of Back Surgery [clinicaltrials:NCT00018876]Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer [clinicaltrials:NCT00020631]Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging [clinicaltrials:NCT00023465]A Study in Adult and Pediatric Patients With Cystic Fibrosis [clinicaltrials:NCT00034515]Gene Modifiers of Cystic Fibrosis Lung Disease [clinicaltrials:NCT00037765]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Fibrosis [clinicaltrials_resource:af970820d839486f4d844e35053538a3]
Bio2RDF identifier
af970820d839486f4d844e35053538a3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:af970820d839486f4d844e35053538a3
identifier
clinicaltrials_resource:af970820d839486f4d844e35053538a3
title
Fibrosis
@en
type
label
Fibrosis [clinicaltrials_resource:af970820d839486f4d844e35053538a3]
@en